Medtronic generated $9,756 million in sales and $1,470 million in Net Income attributable to Medtronic for the three months ended July 31, 2026. Net income rose from $1,040 million, while Diluted Earnings per Share increased to $1.14 from $0.81, giving investors higher reported profitability and per-share earnings.

Key Highlights

  • Diluted earnings per share rose to $1.14 from $0.81 in the comparable period.
  • Operating profit reached $1,764 million, compared with $1,445 million previously.
  • Restructuring charges totaled $72 million, while certain litigation charges were zero.

Medtronic plc (NYSE: MDT) generated $9,756 million ($9.756 billion) in net sales for the three months ended July 31, 2026, compared with $8,578 million in the comparable period. Net income attributable to Medtronic reached $1,470 million, up from $1,040 million. Diluted earnings per share were $1.14, while Basic Earnings Per Share were $1.15. The results show higher revenue, operating profit and attributable earnings in the reported quarter. Basic weighted average shares outstanding were 1,279,800,000, and diluted weighted average shares outstanding were 1,285,100,000.

Quarterly Profit And Sales

Operating profit increased to $1,764 million from $1,445 million. Income before income taxes was $1,769 million, compared with $1,302 million in the comparable period. Net income was $1,479 million, up from $1,047 million. The income tax provision was $289 million, compared with $255 million. Interest expense, net, reached $186 million from $176 million, while other non-operating income, net, was $190 million compared with $33 million.

Expense Lines Shape Results

Research and development expense increased to $771 million from $726 million. Selling, general and administrative expense was $3,198 million, compared with $2,806 million. Restructuring charges, net, were $72 million, compared with $45 million. Certain litigation charges, net, were zero in the reported period compared with $27 million in the comparable period. Other operating income, net, was $123 million, compared with $70 million.

Earnings Per Share Advances

Basic earnings per share increased to $1.15 from $0.81. Diluted earnings per share rose to $1.14 from $0.81. As of August 28, 2026, 1,279,137,890 ordinary shares were outstanding.

Quarterly Results In Perspective

Medtronic’s reported sales were $9,756 million for the three months ended July 31, 2026, compared with $8,578 million for the three months ended July 25, 2025. The quarter also produced $1,764 million in operating profit and $1.14 in diluted earnings per share.